| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Minerva Neurosciences, Inc. (NERV) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 5 sells. NERV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.25M | $13.42M | - | |
| Pres | 1.50M | $8.95M | - | |
| CFO | 500.0K | $2.98M | - | |
| Dir | 364.5K | $2.17M | - | |
| Dir | 50.0K | $298.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2019 | Race Geoff | EVP, CFO &Cbo | Sale+OE | 5,826 | $7.10 | $41,364.60 | -2.8% | |
| Dec 17, 2019 | Luthringer Remy | CEO | Sale+OE | 2,412 | $7.10 | $17,125.20 | -4.7% | |
| Dec 17, 2019 | Ahlholm Frederick W | SVP, Chief Accounting Officer | Sale+OE | 1,557 | $7.10 | $11,054.70 | -9.3% | |
| Dec 17, 2019 | Reilly Joseph H. | SVP &Chief Operating Officer | Sale+OE | 2,724 | $7.10 | $19,340.40 | -9.4% | |
| Dec 12, 2019 | Russell Richard E. | President | Sell | 3,113 | $7.42 | $23,098.46 | -8.4% | |
| Jun 27, 2019 | Doyle William F53 | Director | Buy | 3,500 | $5.50 | $19,250.00 | +15.5% | |
| Jun 26, 2019 | Van Heek G Jan | Director | Buy | 10,000 | $5.37 | $53,700.00 | +300.0% | |
| Jun 26, 2019 | Hilleman Jeryl L64 | Director | Buy | 1,000 | $5.25 | $5,250.00 | New | |
| Jun 26, 2019 | Kupfer David | Director | Buy | 10,000 | $5.55 | $55,500.00 | +4.8% | |
| Jun 26, 2019 | Hasler Hans Peter | Director | Buy | 10,000 | $5.60 | $56,000.00 | New |